The 2nd CRISPR-Based Therapy Analytical Development Summit is held on 17-19 September 2024 in **Boston, MA.** As CRISPR-based therapies become ever complex, drug developers urgently need to innovate the analytical tools available to effectively characterize their safety and efficacy profiles and agree upon gold standards moving forward. We are also witnessing increased regulatory scrutiny, with the FDA closely studying off-target analysis conducted ahead of the approval of Casgevy, prior to finalizing guidance on genome editing therapies in January.Expert discussions will highlight analytical innovation with both traditional and disruptive CRISPR-based therapies, and span in vivo and ex vivo delivery.If you are working to develop, characterize, and validate more robust analytical tools to enable the progression of your early R and D work into a clinical therapy, this is your collaborative forum to equip you with the latest innovation, case studies, and actionable insights to level up your analytical efforts.

 [Read on crispr-analytical-development.com](https://crispr-analytical-development.com/take-part/register/)

Continue reading at crispr-analytical-development.com

Health and Wellness

Facebook Share

Twitter Share

Linkedin Share

Email Share